Marc H. Hedrick

Companies

• Plus TherapeuticsChief executive officer Apr 15, 2014 to now¹
• Plus TherapeuticsBoard member Aug 14, 2008 to now²
• Plus TherapeuticsPresident Jan 26, 2006 to Jul 27, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Plus Therapeutics CNSY44,483 shares⁴$72.5K at $1.63Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Exercised options 1,986 shares of Plus Therapeutics⁴
• Jul 1, 2026Exercised options 8,066 shares of Plus Therapeutics⁴
• Jul 1, 2026Exercised options 6,387 shares of Plus Therapeutics⁴
• Apr 1, 2026Exercised options 201,632 shares of Plus Therapeutics⁵
• Apr 1, 2026Exercised options 159,681 shares of Plus Therapeutics⁵
• Jan 1, 2026Exercised options 159,681 shares of Plus Therapeutics⁶
• Oct 1, 2025Exercised options 159,681 shares of Plus Therapeutics⁷
• Sep 10, 2024Bought 8,000 shares at $1.23 of Plus Therapeutics⁸
• May 8, 2024Bought 12,255 shares at $2.04 of Plus Therapeutics⁹
• Nov 20, 2023Sold 2,068 shares at $1.96 of Plus Therapeutics¹⁰
• Jun 15, 2022Bought 5,000 shares at $0.65 of Plus Therapeutics¹¹
• Apr 26, 2022Bought 2,500 shares at $0.68 of Plus Therapeutics¹²
• Apr 26, 2022Bought 5,000 shares at $0.69 of Plus Therapeutics¹³
• Oct 26, 2021Bought 2,500 shares at $1.66 of Plus Therapeutics¹⁴